Exhibit 1
EXECUTION COPY
THE BANK OF NEW YORK COMPANY,
INC
Senior Medium-Term Notes Series
F
Senior Subordinated Medium-Term
Notes Series G
Due Nine Months or More from Date
of Issue
DISTRIBUTION
AGREEMENT
September 10, 2004
|
|
|
|
|
Banc of America Securities LLC
9 West 57 th Street
New York, New York 10019
|
|
Citigroup Global Markets Inc.
390 Greenwich Street
New York, New York 10013
|
|
|
|
|
Credit Suisse First Boston LLC
11 Madison Avenue
New York, New York 10010
|
|
Goldman, Sachs & Co.
85 Broad Street
New York, New York 10004
|
|
|
|
|
Lehman Brothers Inc.
745 Seventh Avenue
New York, New York 10019
|
|
Merrill Lynch, Pierce, Fenner &
Smith
Incorporated
4 World Financial Center
New York, New York 10080
|
|
|
|
|
Morgan Stanley & Co. Incorporated
1585 Broadway
New York, New York 10036
|
|
UBS Securities LLC
677 Washington Blvd.
Stamford, Connecticut
06901
|
|
|
|
|
BNY Capital Markets, Inc.
One Wall Street
New York, New York 10286
|
|
|
Ladies and Gentlemen:
The Bank of New York Company, Inc.,
a New York corporation (the “Company”), confirms its
agreement with Banc of America Securities LLC, Citigroup Global
Markets Inc., Credit Suisse First Boston LLC, Goldman, Sachs &
Co., Lehman Brothers Inc., Merrill Lynch, Pierce, Fenner &
Smith Incorporated, Morgan Stanley & Co. Incorporated, UBS
Securities LLC and BNY Capital Markets, Inc. (the
“Agents”) with respect to the issue and sale by the
Company from time to time of its Senior Medium-Term Notes Series F
(the “Senior Notes”) and its Senior Subordinated
Medium-Term Notes Series G (the “Senior Subordinated
Notes” and, together with the Senior Notes, the
“Notes”) described herein. The Senior Notes are to be
issued pursuant to an indenture dated as of July 18, 1991, as it
may be supplemented from time to time (the “Senior
Indenture”), between the Company and
Deutsche Bank Trust Company Americas (formerly known as Bankers
Trust Company), as trustee (the “Senior Trustee”). The
Senior Subordinated Notes are to be issued pursuant to an indenture
dated as of October 1, 1993, as it may be supplemented from time to
time (the “Senior Subordinated Indenture” and, together
with the Senior Indenture, the “Indentures”), between
the Company and J.P. Morgan Trust Company (successor by merger to
Chase Manhattan Trust Company, National Association), as trustee
(the “Senior Subordinated Trustee” and, together with
the Senior Trustee, the “Trustees”). As of the date
hereof, the Company has authorized the issuance and sale of up to
an aggregate initial offering price not to exceed U.S.
$1,000,000,000 (or its equivalent, based upon the applicable
exchange rate at the time of issuance, in such foreign currencies
as the Company shall designate at the time of issuance) of Notes to
or through the Agents pursuant to the terms of this Agreement. It
is understood, however, that the Company may from time to time
authorize the issuance of additional Notes and that such additional
Notes may be sold through or to the Agents pursuant to the terms of
this Agreement, all as though the issuance of such Notes were
authorized as of the date hereof.
This Agreement provides both for the
sale of Notes by the Company directly to purchasers, in which case
the Agents will act as agents of the Company in soliciting Note
purchasers, and (as may from time to time be agreed to by the
Company and any Agent or Agents) to such Agent or Agents as
principal for resale to purchasers.
The Company has filed with the
Securities and Exchange Commission (the “SEC”) a
registration statement on Form S-3 (Nos. 333-116460, 333-116460-01,
333-116460-02 and 333-116460-03) for the registration of, among
other securities, debt securities, including the Notes, under the
Securities Act of 1933, as amended (the “1933 Act”),
and the offering thereof from time to time in accordance with Rule
415 of the rules and regulations of the SEC under the 1933 Act (the
“1933 Act Regulations”). Such registration statement
has been declared effective by the SEC and the Indentures have been
qualified under the Trust Indenture Act of 1939, as amended (the
“1939 Act”). Such registration statement (and any
further registration statement that may be filed by the Company for
the purpose of registering additional Notes and in connection with
which this Agreement is included or incorporated by reference as an
exhibit) and the prospectus constituting a part thereof, and any
prospectus supplements relating to the Notes, including all
documents incorporated therein by reference, as from time to time
amended or supplemented by the filing of documents pursuant to the
Securities Exchange Act of 1934, as amended (the “1934
Act”), or the 1933 Act or otherwise, are referred to herein
as the “Registration Statement” and the
“Prospectus,” respectively, except that if any revised
prospectus shall be provided to the Agents by the Company for use
in connection with the offering of the Notes that is not required
to be filed by the Company pursuant to Rule 424(b) of the 1933 Act
Regulations, the term “Prospectus” shall refer to such
revised prospectus from and after the time it is first provided to
the Agents for such use.
SECTION 1. Appointment as
Agents.
(a) Appointment of
Agents
Subject to the terms and conditions
stated herein, the Company hereby appoints the Agents as its agents
for the purpose of soliciting purchases of the Notes from the
Company by
2
others and agrees that, whenever the Company
determines to sell Notes directly to the Agents as principal for
resale to others, it will enter into a Terms Agreement (hereafter
defined) relating to such sale in accordance with the provisions of
Section 3(b) hereof. The Agents are authorized to appoint
sub-agents or to engage the services of any other broker or dealer
in connection with the offer or sale of the Notes. The Company may
also sell Notes directly to investors on its own behalf, including
to agents that are not party to this Agreement and may enter into
agreements similar to this Agreement with other parties;
provided, however , that the Company shall notify the Agents
upon entering into any such agreement that is substantially similar
to this Agreement.
(b) Best Efforts Solicitations;
Rights to Reject Offers
Upon receipt of instructions from
the Company, the Agents will use their best efforts to solicit
purchases of such principal amount of the Notes as the Company and
the Agents shall agree upon from time to time during the term of
this Agreement, it being understood that the Company shall not
approve the solicitation of purchases of Notes in excess of the
amount that shall be authorized by the Company from time to time.
The Agents will communicate to the Company, orally or in writing,
each offer to purchase Notes, other than those offers rejected by
each Agent. Each Agent shall have the right, in its discretion
reasonably exercised, to reject any proposed purchase of Notes, as
a whole or in part, and any such rejection shall not be deemed a
breach of such Agent’s agreement contained herein. The
Company may accept or reject any proposed purchase of the Notes, in
whole or in part.
(c) Solicitations as Agent;
Purchases as Principal
If agreed upon between an Agent and
the Company, such Agent, acting solely as an agent for the Company
and not as principal, will solicit offers for the purchase of
Notes. Each Agent shall make reasonable efforts to assist the
Company in obtaining performance by each purchaser whose offer to
purchase Notes has been solicited by such Agent and accepted by the
Company. The Agents shall not have any liability to the Company in
the event any such purchase is not consummated for any reason. The
Agent shall not have any obligation to purchase Notes from the
Company as principal, but each Agent may agree from time to time to
purchase Notes as principal. However, absent an agreement between
an Agent and the Company that such Agent shall be acting solely as
an agent for the Company, such Agent shall be deemed to be acting
as principal in connection with any offering of Notes by the
Company through such Agent. Any such purchase of Notes by an Agent
as principal shall be made pursuant to a Terms Agreement in
accordance with Section 3(b) hereof.
(d) Reliance
The Company and the Agents agree
that any Notes the placement of which an Agent arranges shall be
placed by such Agent, and any Notes purchased by an Agent shall be
purchased, in reliance on the representations, warranties,
covenants and agreements of the Company contained herein and on the
terms and conditions and in the manner provided herein.
3
SECTION 2. Representations and
Warranties .
(a) The Company represents and
warrants to the Agents as of the date hereof, as of the date of
each acceptance by the Company of an offer for the purchase of
Notes (whether through an Agent as agent or to an Agent as
principal), as of the date of each delivery of Notes (whether
through an Agent as agent or to an Agent as principal) (the date of
each such delivery to an Agent as principal being hereafter
referred to as a “Settlement Date”), and as of the
times referred to in Section 7(b) hereof (in each case, the
“Representation Date”) as follows:
(i) Due Incorporation . Each
of the Company and The Bank of New York (the “Bank”)
has been duly organized and is validly existing as a corporation or
banking corporation, as the case may be, and is an existing
corporation or banking corporation, as the case may be, in good
standing under the laws of the State of New York.
(ii) Registration Statement and
Prospectus . The Registration Statement and the Prospectus, at
the time the Registration Statement became effective, conformed,
and as of the applicable Representation Date will conform, in all
material respects to the requirements of the 1933 Act, the 1933 Act
Regulations and the 1939 Act. The Registration Statement, at the
time the Registration Statement became effective, did not, and as
of the applicable Representation Date will not, contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein not misleading. The Prospectus, at the date hereof does
not, and as of the applicable Representation Date will not, contain
an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; provided, however , that the representations and
warranties in this subsection shall not apply to any statements in
or omissions from the Registration Statement or the Prospectus made
in reliance upon and in conformity with information furnished to
the Company in writing by an Agent expressly for use in the
Registration Statement or the Prospectus (it being agreed that, for
purposes of this subsection (ii) and Section 8 hereof, the only
information so furnished by any Agent as of the date hereof
consists of (x) the last two sentences in the fifth paragraph and
(y) the seventh paragraph, in each case, under “Plan of
Distribution of Medium-Term Notes” in the prospectus
supplement dated the date hereof relating to the Notes) or to that
part of the Registration Statement that shall constitute the
Statement of Eligibility under the 1939 Act (the “Form
T-l”) of the Trustees.
(iii) Incorporated Documents
. The documents incorporated by reference in the Prospectus, at the
time they were or hereafter are filed with the SEC, conformed and
will conform in all material respects to the requirements of the
1933 Act and the 1933 Act Regulations or the 1934 Act and the rules
and regulations thereunder (the “1934 Act
Regulations”), as applicable, and, when read together and
with the other information in the Prospectus, at the date hereof
does not and, as of the applicable Representation Date will not,
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under
which they were or are made, not misleading.
(iv) Material Change . Since
the respective dates as of which information is given in the
Registration Statement and the Prospectus, there has not been any
material
4
adverse change, or any development
involving a prospective material adverse change, in the
credit-worthiness of the Company and its subsidiaries on a
consolidated basis, other than as set forth or contemplated in the
Prospectus.
(v) No Defaults; Regulatory
Approvals . The issue and sale of the Notes and the compliance
by the Company with all of the provisions of the Notes, the
Indentures, this Agreement and each applicable Terms Agreement, if
any, and the consummation of the transactions contemplated herein
and therein will not conflict with or result in a breach of any of
the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any of
its subsidiaries pursuant to the terms of, any indenture, contract,
mortgage, deed of trust, loan agreement, note, lease or other
agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject, nor will such
action result in any violation by the Company of the provisions of
the Certificate of Incorporation, as amended, or By-Laws of the
Company, or any statute or any order, rule or regulation of any
court or governmental agency or body having jurisdiction over the
Company or any of its subsidiaries or any of its properties, and no
consent, approval, authorization, order, registration or
qualification of or with any court or any such regulatory authority
or other governmental agency or body is required for the issue and
sale of the Notes or the consummation of the other transactions
contemplated by this Agreement or any Terms Agreement or the
Indentures, except such as may be required under the 1933 Act, the
1939 Act and the 1933 Act Regulations and such consents, approvals,
authorizations, registrations or qualifications as may be required
under state securities or blue sky laws in connection with the
purchase and distribution of the Notes by the Agent.
(vi) Authorization and
Validity . The Notes have been duly authorized by the Company
for issuance and sale pursuant to this Agreement and, when issued,
authenticated and delivered pursuant to the provisions of this
Agreement and of the Indenture under which it is to be issued
against payment of the consideration therefor specified herein, the
Notes will constitute valid and legally binding obligations of the
Company entitled to the benefits provided by such Indenture; this
Agreement has been duly authorized, executed and delivered by the
Company; each Indenture has been duly authorized, executed and
delivered by the Company, has been duly qualified under the 1939
Act and constitutes a valid and legally binding instrument of the
Company, enforceable against the Company in accordance with its
terms, subject to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors’ rights and
to general equity principles; and the Indentures conform and the
Notes of any particular issuance will conform to the descriptions
thereof in the Prospectus.
(vii) Capitalization . All of
the issued shares of capital stock of the Bank have been duly and
validly authorized and issued, are fully paid and non-assessable
(except as provided in Article III of the Banking Law of the State
of New York) and are owned by the Company, free and clear of all
liens, encumbrances, equities or claims.
5
(viii) Legal Proceedings .
Except as otherwise disclosed in the Prospectus, there is no
action, suit or proceeding before or by any court or governmental
agency domestic or foreign, now pending or, to the knowledge of the
Company, threatened against or affecting the Company or its
subsidiaries that might result in any material adverse change in
the financial condition, shareholders’ equity or results of
operations of the Company and its subsidiaries considered as one
enterprise.
(ix) Ratings . The Senior
Notes and the Senior Subordinated Notes are rated Aa3 and A1,
respectively, by Moody’s Investors Service, Inc. and A+ and
A, respectively, by Standard & Poor’s Ratings Services,
or such other ratings as to which the Company shall have most
recently notified the Agents pursuant to Section 4(a)
hereof.
(b) Additional
Certifications
Any certificate signed by any
officer of the Company and delivered to the Agents or to counsel
for the Agents in connection with an offering of Notes or the sale
of the Notes to the Agent as principal shall be deemed a
representation and warranty by the Company to the Agents as to the
matters covered thereby on the date of such certificate and at each
Representation Date referred to in Section 2(a) hereof subsequent
thereto.
SECTION 3. Solicitations as
Agent; Purchases as Principal.
(a) Solicitations as
Agent
On the basis of the representations
and warranties herein contained, but subject to the terms and
conditions herein set forth, each Agent agrees, as an agent of the
Company, to use its best efforts to solicit offers to purchase the
Notes upon the terms and conditions set forth herein and in the
Prospectus.
The Company reserves the right, in
its sole discretion, to suspend solicitation of purchases of the
Notes through the Agents, as agents, commencing at any time for any
period of time or permanently. Upon receipt of instructions from
the Company, the Agents will forthwith suspend solicitation of
purchases from the Company until such time as the Company has
advised the Agents that such solicitation may be
resumed.
Unless otherwise agreed to by the
Company and the applicable Agent with respect to sales made to
retail investors, the Company agrees to pay such Agent a
commission, in the form of a discount, equal to the applicable
percentage of the amount of the principal amount of each Note sold
by the Company as a result of a solicitation made by such Agent as
set forth in Schedule A hereto. Each Agent may re-allow any portion
of the commission payable pursuant hereto to dealers or purchasers
in connection with the offer and sale of any Notes; provided,
however , that such Agent shall obtain the prior written
consent of the Company to any such reallowance.
The purchase price, interest rate,
maturity date and other terms of the Notes shall be agreed upon by
the Company and the applicable Agent and set forth in a pricing
supplement to the Prospectus (a “Pricing Supplement”)
to be prepared following each acceptance by the Company of an offer
for the purchase of Notes. Except as may be otherwise provided in
the
6
Pricing Supplement ( i.e. , in the case
of foreign currency denominated Notes), the Notes will be issued in
denominations of U.S. $1,000 or any amount in excess thereof that
is an integral multiple of U.S. $1,000. All Notes sold through an
Agent as agent will be sold at 100% of their principal amount
unless otherwise agreed to by the Company and such
Agent.
(b) Purchases as
Principal
Each sale of Notes to an Agent or
Agents as principal shall be made in accordance with the terms
contained herein and (unless the Company and such Agent or Agents
shall otherwise agree) pursuant to a separate agreement that will
provide for the sale of such Notes to, and the purchase and
reoffering thereof by, such Agent or Agents. Each such separate
agreement (which may be an oral agreement promptly confirmed in
writing as described below) between an Agent or Agents and the
Company is herein referred to as a “Terms Agreement.”
Unless the context otherwise requires, each reference contained
herein to “this Agreement” shall be deemed to include
any applicable Terms Agreement between the Company and an Agent or
Agents. Each such Terms Agreement, whether oral (and promptly
confirmed in writing, which may be by facsimile transmission) or in
writing, shall be with respect to such information (as applicable)
as is specified in Annex I hereto. Each Agent’s commitment to
purchase Notes as principal pursuant to any Terms Agreement (or
otherwise) shall be deemed to have been made on the basis of the
representations and warranties of the Company herein contained and
shall be subject to the terms and conditions herein set forth. Each
Terms Agreement shall specify the principal amount of Notes to be
purchased by an Agent or Agents pursuant thereto, the price to be
paid to the Company for such Notes (which, if not so specified in a
Terms Agreement, shall be at a discount equivalent to the
applicable commission set forth on Schedule A to the applicable
Terms Agreement), the time and place of delivery of and payment for
such Notes, any provision relating to rights of and defaults by
other purchasers acting together with such Agent or Agents in the
reoffering of the Notes and such other provisions (including
further terms of the Notes) as may be mutually agreed upon. Each
Agent is authorized to utilize a selling or dealer group in
connection with the resale of the Notes purchased; provided,
however , that such Agent shall obtain the prior written
consent of the Company to such utilization. Such Terms Agreement
shall also specify the requirements, if any, for the opinions of
counsel, letters of the Company’s independent registered
public accountants and officer’s certificate pursuant to
Sections 7(b), 7(c) and 7(d) hereof.
(c) Administrative
Procedures
Administrative procedures with
respect to the sale of Notes shall be agreed upon from time to time
by the Agents and the Company (the “Procedures”). The
Agents and the Company agree to perform the respective duties and
obligations specifically provided to be performed by them in the
Procedures.
7
SECTION 4. Covenants of the
Company
The Company covenants with the
Agents as follows:
(a) Notice of Certain
Events
The Company will notify the Agents
immediately of (i) the effectiveness of any amendment to the
Registration Statement, (ii) the mailing or the delivery to the SEC
for filing of any supplement to the Prospectus or any document to
be filed pursuant to the 1934 Act that will be incorporated by
reference in the Prospectus, (iii) the receipt of any comments from
the SEC with respect to the Registration Statement or the
Prospectus, (iv) any request by the SEC for any amendment to the
Registration Statement or any amendment or supplement to the
Prospectus or for additional information, (v) the issuance by the
SEC of any stop order suspending the effectiveness of the
Registration Statement or the initiation of any proceedings for
that purpose or (vi) any change in the rating assigned by any
“nationally recognized statistical rating organization”
(as defined for purposes of Rule 436(g) under the 1933 Act
Regulations) to any debt securities (including the Notes) of the
Company, or the public announcement by any such nationally
recognized statistical rating organization that it has under
surveillance or review, with possible negative implications, its
rating of any such debt securities, or the withdrawal by any such
nationally recognized statistical rating organization of its rating
of any such debt securities. The Company will use its reasonable
best efforts to prevent the issuance of any stop order with respect
to the Registration Statement and, if any such stop order is
issued, to obtain the lifting thereof at the earliest possible
moment.
(b) Filing of Amendments and
Supplements to Prospectus and Registration Statement
Prior to the termination of the
offering of the Notes (including by way of resale by a Purchaser of
Notes purchased pursuant to a Terms Agreement), the Company will
not file any registration statement with respect to the
registration of additional Notes or any amendment to the
Registration Statement or any amendment or supplement to the
Prospectus (other than an amendment or supplement (i) providing
solely for a change in the interest rate of the Notes or (ii)
relating exclusively to an offering of securities other than the
Notes) unless the Company has delivered to the Agents a copy for
review prior to filing and will not file any such proposed
amendment or supplement to which any of the Agents reasonably
objects; and the Company will cause each supplement to the
Prospectus (including each Pricing Supplement) to be filed with the
Commission pursuant to the applicable paragraph of Rule 424(b)
within the time period prescribed thereby and, upon request, will
provide evidence satisfactory to the Agents of such
filing.
(c) Copies of the Registration
Statement and the Prospectus
The Company will deliver to the
Agents as many signed and conformed copies of the Registration
Statement (as originally filed) and of each amendment thereto
(including exhibits filed therewith or incorporated by reference
therein and documents incorporated by reference in the Prospectus)
as the Agents may reasonably request. The Company will furnish to
the Agents as many copies of the Prospectus (as amended or
supplemented) as the Agents shall reasonably request so long as the
Agents are required to deliver a Prospectus in connection with
sales or solicitations of offers to purchase the Notes.
(d) Prospectus Revisions —
Material Change
If at any time when the Prospectus
is required by the 1933 Act to be delivered in connection with
sales of the Notes any event shall occur or condition exist as a
result of which it
8
is necessary to further amend or supplement the
Prospectus in order that the Prospectus will not include an untrue
statement of a material fact or omit to state any material fact
necessary in order to make the statements therein not misleading in
the light of the circumstances existing at the time it is delivered
to a purchaser, or if it shall be necessary at any such time to
amend or supplement the Registration Statement or the Prospectus in
order to comply with the requirements of the 1933 Act or the 1933
Act Regulations, immediate notice shall be given, and confirmed in
writing, to the Agents to cease the solicitation of offers to
purchase the Notes in their capacity as agent and to cease sales of
any Notes it may then own as principal, and the Company will
promptly prepare and file with the SEC such amendment or
supplement, whether by filing documents pursuant to the 1934 Act,
the 1933 Act or otherwise, as may be necessary to correct such
untrue statement or omission or to make the Registration Statement
comply with such requirements.
(e) Prospectus Revisions —
Periodic Financial Information
On or prior to the date on which
there shall be released to the general public interim financial
statement information related to the Company with respect to each
of the first three quarters of any fiscal year or preliminary
financial statement information with respect to any fiscal year,
and prior to the filing of the Forms 10-Q or 10-K with respect to
such quarters or fiscal years, the Company shall furnish such
information to the Agents, confirmed in writing, and shall cause
the Prospectus to incorporate by reference capsule financial
information with respect to the results of operations of the
Company for the period between the end of the preceding fiscal year
and the end of such quarter or for such fiscal year, as the case
may be, and corresponding information for the comparable period of
the preceding fiscal year, as well as such other information and
explanations as shall be necessary for an understanding of such
amounts or as shall be required by the 1933 Act or the 1933 Act
Regulations; provided, however , that if on the date of such
release the Agents shall have suspended solicitation of purchases
of the Notes in their capacity as agent pursuant to a request from
the Company, and the Agents shall not then hold any Notes as
principal, the Company shall not be obligated so to amend or
supplement the Prospectus until such time as the Company shall
determine that solicitation of purchases of the Notes should be
resumed or shall subsequently enter into a new Terms Agreement with
an Agent, and provided further that this covenant shall not
obligate the Company to incorporate financial information or
discussion other than that contained in its regular earnings press
release with respect to such quarter or year.
(f) Prospectus Revisions —
Audited Financial Information
On or prior to the date on which
there shall be released to the general public financial information
included in or derived from the audited financial statements of the
Company for the preceding fiscal year, the Company shall cause the
Registration Statement and the Prospectus to be amended, whether by
the filing of documents pursuant to the 1934 Act, the 1933 Act or
otherwise, to include or incorporate by reference such audited
financial statements and the report or reports, and consent or
consents to such inclusion or incorporation by reference, of the
independent accountants with respect thereto, as well as such other
information and explanations as shall be necessary for an
understanding of such financial statements or as shall be required
by the 1933 Act or the 1933 Act Regulations; provided,
however , that if on the date of such release the Agents shall
have suspended solicitation of purchases of the Notes in their
capacity as agents
9
pursuant to a request from the Company, and the
Agents shall not then hold any Notes as principal, the Company
shall not be obligated so to amend or supplement the Prospectus
until such time as the Company shall determine that solicitation of
purchases of the Notes should be resumed or shall subsequently
enter into a new Terms Agreement with an Agent.
(g) Earning
Statements
The Company will make generally
available to its security holders as soon as practicable, but not
later than 60 days after the close of the period covered thereby,
an earning statement of the Company and its subsidiaries (which
need not be audited) in form complying with the provisions of Rule
158 of the 1933 Act Regulations, covering each twelve-month period
beginning, in each case, not later than the first day of the
Company’s fiscal quarter next following the “effective
date” (as defined in such Rule 158) of the Registration
Statement with respect to each sale of Notes.
(h) Blue Sky
Qualifications
The Company will endeavor, in
cooperation with the Agents, to qualify the Notes for offering and
sale under the applicable securities laws of such states and other
jurisdictions of the United States as the Agents may designate, and
will maintain such qualifications in effect for as long as may be
required for the distribution of the Notes; provided,
however , that the Company shall not be obligated to file any
general consent to service of process or to qualify as a foreign
corporation in any jurisdiction in which it is not so qualified.
The Company will file such statements and reports as may be
required by the laws of each jurisdiction in which the Notes have
been qualified as above provided. The Company will promptly advise
the Agents of the receipt by the Company of any notification with
respect to the suspension of the qualification of the Notes for
sale in any such state or jurisdiction or the initiating or
threatening of any proceeding for such purpose.
(i) 1934 Act
Filings
The Company, during the period when
the Prospectus is required to be delivered under the 1933 Act in
connection with sales of the Notes, will file promptly all
documents required to be filed with the SEC pursuant to Section
13(a), 13(c), 14 or 15(d) of the 1934 Act.
(j) Stand-Off
Agreement
Between the date of any Terms
Agreement and the Settlement Date with respect to such Terms
Agreement, the Company will not, without the prior consent of the
applicable Agents, which consent shall not be unreasonably
withheld, offer or sell in the United States, or enter into any
agreement to sell in the United States, any debt securities of the
Company (other than the Notes) that are substantially similar to
the Notes except as may otherwise be provided in any such Terms
Agreement.
10
(k) Annual Reports
The Company will furnish to the
Agents, at the earliest time the Company makes the same available
to others, copies of its annual reports and other financial reports
furnished or made available to the public generally.
SECTION 5. Conditions of
Obligations
The obligations of the Agents to
solicit offers to purchase the Notes as agents of the Company, the
obligations of any purchasers of the Notes sold through the Agents
as agents, and any obligation of an Agent to purchase Notes
pursuant to a Terms Agreement (or otherwise), will be subject to
the accuracy of the representations and warranties on the part of
the Company herein and to the accuracy of the statements of the
Company’s officers made in any certificate furnished pursuant
to the provisions hereof, to the performance and observance by the
Company of all its covenants and agreements herein contained and to
the following additional conditions precedent:
(a) Legal Opinions
On the date the program commences
(the “Commencement Date”), the Agents shall have
received the following legal opinions, dated as of the date hereof
and in form and substance satisfactory to the Agents:
(1) Opinion of Company
Counsel . The opinion of Paul A. Immerman, Esq., Senior Counsel
to the Company, or other counsel satisfactory to the Agents, to the
effect that:
(i) Each of the Company and the Bank
has been duly incorporated and is an existing corporation or
banking corporation, respectively, in good standing under the laws
of the State of New York, and the Company has the corporate power
and authority to own its properties and conduct its business as
described in the Prospectus.
(ii) Each Indenture has been duly
authorized, executed and delivered by the Company and duly
qualified under the 1939 Act and constitutes a valid and legally
binding obligation of the Company enforceable against the Company
in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability relating to or affecting creditors’
rights and to general equity principles.
(iii) The Notes have been duly
authorized and established by the Company in conformity with the
applicable Indenture, and when the terms of a particular Note and
of its issuance and sale have been duly authorized and established
by all necessary corporate action on the part of the Company in
conformity with such Indenture and such Note has been duly
prepared, executed, authenti